This is the web site of Interpharm Consultancy. If you want to know about generic pharmaceuticals - please contact us to see how we can help

30 years’ experience of the European pharmaceutical industry in general and 20 years in generics in particular gives Interpharm the background to help you with whatever issues you may be facing.

Expertise

Whether you are thinking about:

• - Business development,
• - Introducing your generic products into Europe
• - Market intelligence and pricing
• - Assistance with product licensing (in or out)
• - How to devise an effective defence strategy to protect your brands
• against generic competition,
• - Bioequivalence studies for your generic developments

please contact us. We can also help with in-house training that is tailored to your company’s individual needs on topics such as understanding the generic market and the legal and IP issues that affect it. To find out more about training and symposia and previous speaking engagements at conferences, please follow the link.

Interpharm has been co-operating with SMi during 2010 and 2011 to run a series of workshops in London onthe topic of biosimilars and will be running a further workshop for them in London in December 2011.

The Biosimilars Workshop is also available as a half-day in-house seminar. Please click on the link to download the programme

Please click here to obtain an overview of the other services that Interpharm can offer including a new on-line patent database.

What we do

Interpharm Consultancy has been serving the generic pharmaceutical industry since 1997. With a background of over 20 years in generics, we specialise in:-

• advising on growth strategies or market entry strategies 
• helping with business development
• competitive intelligence
• providing a link between firms in the UK and overseas companies trying to gain entry into this very competitive marketplace
• training on understanding the generic marketplace, IP and regulatory issues
• locating products and registration dossiers for UK companies and
• assisting branded companies to plan their defence strategies against generics
• offering help to companies looking for generic acquisitions

Examples of previous projects

Interpharm has worked with a number of companies on a variety of generic related projects. Here are a few examples of these assignments:

Generic companies (generally for non-EU clients)

• Identified potential business partners for companies trying to enter EU generic market
• Organised meetings and helped negotiate deals with generic multinationals
• Supplied business intelligence and competitors
• Researched competitor prices across 20+ EU states
• Provided information on legal and regulatory framework to identify best registration method and timing
• Researched market potential for new developments and helped to select target markets
• Identified potential patent problems and advised on possible solutions
• Assisted with resolving GMP deficiencies identified in audit by regulatory authority
• Found Marketing Authorisations or dossiers for specific target products on behalf of clients

Some clients have asked for more than one of these services them and some activities have been carried out for several clients

Branded companies

• Researched potential generic competition to brands with imminent patent expiry
• Advised on strategies for possible entry into the generics business
• Advised on strategies for dealing with generic competition (several companies)
• Run seminars for senior management on the generic industry and how it differs from branded pharma
• Advised branded company on possible strategies for launching their own generic
• Conducted various ad-hoc market research projects, not always related to generics

Recent reports

To learn more about a recent report on Biosimilars and Biobetters please click on the link to Biobetters: Major Players and Market Prospects published by FirstWord for further information or see the News page. The report looks at the biobetters market and how interest has mounted in what is still a very young market. The report reviews the role Biosimilars have played, presents the rationale behind biobetters and how interest is is stirring in their development. In addition, the report concisely outlines how companies are evolving biobetters, the areas of greatest potential and reviews the ‘Achilles Heel’ of immunogenicity.

Recent articles

If you are interested to read a recent article about the generic industry that appeared in the GenericsWeb INNsight newsletter, please follow the link. For news about future speaking engagements please go to the News page.

At this site, you can learn more about Interpharm’s services, as well as how we can help your company to find its way into the UK or other European generic markets.

Interpharm is a London based consultancy managed by Peter Wittner that specialises in the area of generics and that offers advice on issues such as product sourcing, patent expiries, international marketing, bioavailability and bioequivalence studies. With over 30 years’ experience in pharmaceuticals of which 15 have been specifically in the generic field, Interpharm is the partner you need for exploring European generic markets in general and the UK in particular.

Apart from that, I am the author of several reports on the European and US generics industries for publishers such as Decision Resources, Arrowhead Publishing, Business Insights and Informa Pharmaceuticals /URCH Publishing and have spoken at generics symposia. There is more information about this in the Conferences section on the “About Interpharm” page

You are welcome to browse around this site. If you have comments or questions about my products or services, or simply need more information and want to contact me click on the contact button on any page within this site.

Thank you for visiting and I look forward to helping you.